GeneDx
Empowering everyone to live their healthiest life through genomics
- Headquarters
- Stamford
- Employees
- 501–1000
- Founded
- 2000
- Business Model
- B2B
- Website
- genedx.com
- Total Funding
- $1.0B
- Last Round
- $200.0M Corporate RoundJan 2022
About
GeneDx is a genomics company that provides comprehensive genetic testing for rare and undiagnosed conditions. Founded in 2000 by NIH scientists, GeneDx offers whole exome sequencing, whole genome sequencing, and targeted genetic panels to clinicians and patients worldwide. The company has diagnosed over 4,800 genetic diseases and published over 1,000 scientific papers. GeneDx trades on Nasdaq under the ticker WGS and is headquartered in Stamford, Connecticut.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account